Barnérias C, Quijano S, Mayer M, Estournet B, Cuisset J-M, Sukno S, Peudenier S, Laroche C, Chabrier S, Sabouraud P, Vuillerot C, Chabrol B, Halbert C, Cancès C, Beze-Beyrie P, Ledivenah A, Viallard M-L, Desguerre I
Unité de neuropédiatrie, hôpital Necker enfants malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France.
Service de réanimation neuromusculaire, hôpital Raymond-Poincarré, AP-HP, 92380 Garches, France.
Arch Pediatr. 2014 Apr;21(4):347-54. doi: 10.1016/j.arcped.2014.01.017. Epub 2014 Mar 12.
Questions about care practices and the role of palliative care in pediatric neurodegenerative diseases have led the Neuromuscular Committee of the French Society of Neurology to conduct a retrospective study in spinal muscular atrophy type 1, a genetic disease most often leading to death before the age of 1 year.
A retrospective multicenter study from pediatricians included in the reference centers of pediatric neuromuscular diseases was carried out on two 10-year periods (1989-1998 and 1999-2009).
The 1989-1998 period included 12 centers with 106 patients, the 1999-2009 period 13 centers with 116 children. The mean age of onset of clinical signs was 2.1 months (range, 0-5.5 months), the median age at diagnosis was 4 months (range, 0-9 months) vs 3 months. The median age of death was 7.5 months (range, 0-24 months) vs 6 months. The care modalities included physiotherapy (90 %), motor support (61 % vs 26 % for the previous period), enteral nutrition by nasogastric tube (52 % vs 24 %), and 3.4 % of children had a gastrostomy (vs 1.8 %). At home, pharyngeal aspiration was used in 64 % (vs 41 %), oxygen therapy in 8 %, noninvasive ventilatory support in 7 %. The mean age at death was 8.1 months (range, 0-24 months) vs 7 months, the time from diagnosis to death was 4 months vs 3 months. Death occurred at home in 23 % vs 17 %, in a pediatric unit in 62 % vs 41 %. The use of analgesics and sedative drugs was reported in 60 % of cases: 40 % morphine (vs 18 %) and benzodiazepines in 48 % (vs 29 %). Respiratory support was limited mostly to oxygen by nasal tube (55 % vs 54 %), noninvasive ventilation in 9 % of the cases, and intubation and assisted mechanical ventilation (2 %).
These results confirm a change in practices and the development of palliative care in children with a French consensus of practices quite different from the standard care in North-America and closer to the thinking of English medical teams. A prospective study within the 2011 national hospital clinical research program (PHRC 2011) is beginning in order to evaluate practices and the role of families and caregivers.
关于护理实践以及姑息治疗在儿童神经退行性疾病中的作用的问题,促使法国神经病学学会神经肌肉委员会对1型脊髓性肌萎缩症开展一项回顾性研究,这是一种最常导致1岁前死亡的遗传性疾病。
对纳入儿童神经肌肉疾病参考中心的儿科医生进行了一项回顾性多中心研究,研究分两个10年时间段(1989 - 1998年和1999 - 2009年)进行。
1989 - 1998年期间有12个中心,共106例患者;1999 - 2009年期间有13个中心,共116名儿童。临床症状出现的平均年龄为2.1个月(范围0 - 5.5个月),诊断时的中位年龄为4个月(范围0 - 9个月),而之前为3个月。死亡的中位年龄为7.5个月(范围0 - 24个月),而之前为6个月。护理方式包括物理治疗(90%)、运动支持(61%,前一时期为26%)、鼻胃管肠内营养(52%,前一时期为24%),3.4%的儿童进行了胃造口术(前一时期为1.8%)。在家中,64%的患儿采用咽部吸引(前一时期为41%),8%采用吸氧治疗,7%采用无创通气支持。死亡的平均年龄为8.1个月(范围0 - 24个月),而之前为7个月,从诊断到死亡的时间为4个月,而之前为3个月。23%的患儿在家中死亡(前一时期为17%),62%在儿科病房死亡(前一时期为41%)。60%的病例报告使用了镇痛药和镇静药:40%使用吗啡(前一时期为18%),48%使用苯二氮䓬类药物(前一时期为29%)。呼吸支持主要限于鼻导管吸氧(55%,前一时期为54%),9%的病例采用无创通气,2%采用插管和辅助机械通气。
这些结果证实了护理实践的变化以及儿童姑息治疗的发展,法国的实践共识与北美的标准护理有很大不同,更接近英国医疗团队的理念。2011年国家医院临床研究项目(PHRC 2011)内的一项前瞻性研究正在开展,以评估护理实践以及家庭和护理人员的作用。